4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0001213900-17-003270
$HURACIK 0001498382operating
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:15 PM ET
Size
4.7 KB
Accession
0001213900-17-003270
Insider Transaction Report
Form 4
Mohr Erich
Director
Transactions
- Other
Common Stock
2017-03-31$3.20/sh+528$1,690→ 1,943 total
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:15 PM ET
- Size
- 4.7 KB